Cellectis SA (CLLS)
4.04
-0.75
(-15.66%)
USD |
NASDAQ |
Dec 16, 16:00
4.04
0.00 (0.00%)
After-Hours: 19:56
Cellectis Research and Development Expense (Annual): 72.02M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| EDAP TMS SA | 9.100M |
| DBV Technologies SA | 89.90M |
| Genfit SA | 49.59M |
| Ascendis Pharma A/S | 324.02M |
| Akari Therapeutics Plc | 6.986M |